Altimmune
Altimmune focused on the development of products to stimulate robust and durable immune responses for the prevention.
Launch date
Employees
Market cap
€459m
Enterprise valuation
€311m (Public information from Sep 2024)
Share price
$7.57 ALT
Gaithersburg Maryland (HQ)
Authorizing premium user...